DK232885D0 - Immunosuppressivt praeparat - Google Patents

Immunosuppressivt praeparat

Info

Publication number
DK232885D0
DK232885D0 DK232885A DK232885A DK232885D0 DK 232885 D0 DK232885 D0 DK 232885D0 DK 232885 A DK232885 A DK 232885A DK 232885 A DK232885 A DK 232885A DK 232885 D0 DK232885 D0 DK 232885D0
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
immunosuppressive
preparation
aroyl
immuno
Prior art date
Application number
DK232885A
Other languages
English (en)
Other versions
DK232885A (da
Inventor
Unknown
Original Assignee
Rolland Sa A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rolland Sa A filed Critical Rolland Sa A
Publication of DK232885D0 publication Critical patent/DK232885D0/da
Publication of DK232885A publication Critical patent/DK232885A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK232885A 1984-05-25 1985-05-24 Immunosuppressivt praeparat DK232885A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8408200A FR2564831B3 (fr) 1984-05-25 1984-05-25 Nouveaux derives des acides aroyl- ou hydroaroyl n-alcoyl pyrrolyl-2 carboxyliques et nouvelles compositions pharmaceutiques a action immuno-suppressive

Publications (2)

Publication Number Publication Date
DK232885D0 true DK232885D0 (da) 1985-05-24
DK232885A DK232885A (da) 1985-11-26

Family

ID=9304387

Family Applications (1)

Application Number Title Priority Date Filing Date
DK232885A DK232885A (da) 1984-05-25 1985-05-24 Immunosuppressivt praeparat

Country Status (11)

Country Link
US (1) US4617315A (da)
EP (1) EP0167426B1 (da)
JP (1) JPS6110510A (da)
AT (1) ATE49958T1 (da)
AU (1) AU578952B2 (da)
CA (1) CA1251140A (da)
DE (1) DE3575716D1 (da)
DK (1) DK232885A (da)
FR (1) FR2564831B3 (da)
IE (1) IE57994B1 (da)
ZA (1) ZA853886B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0723358B2 (ja) * 1985-11-29 1995-03-15 アルベール ロラン エス． アー． ピロールの新規アロイル誘導体
FR2641464B1 (fr) * 1989-01-06 1994-06-03 Rolland Sa A Nouvelles compositions pharmaceutiques manifestant des proprietes inhibitrices vis-a-vis de la phospholipase a2
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3752826A (en) * 1970-01-26 1973-08-14 Mcneilab Inc Aroyl substituted pyrroles
GB1592996A (en) * 1977-10-10 1981-07-15 Rolland Sa A Acylated pyrrole carboxylic acids and derivatives thereof
AU4091178A (en) * 1977-10-25 1980-04-24 Merck & Co Inc Substituted mercapto acid amides
JPS54128567A (en) * 1978-03-28 1979-10-05 Teijin Ltd 1-substituted-4-acyl-2-pyrrolecarboxylic acid derivative

Also Published As

Publication number Publication date
IE851229L (en) 1985-11-25
ZA853886B (en) 1986-08-27
AU4288285A (en) 1985-11-28
FR2564831B3 (fr) 1986-09-05
IE57994B1 (en) 1993-06-02
ATE49958T1 (de) 1990-02-15
EP0167426A1 (fr) 1986-01-08
JPH0553772B2 (da) 1993-08-10
AU578952B2 (en) 1988-11-10
DE3575716D1 (de) 1990-03-08
JPS6110510A (ja) 1986-01-18
EP0167426B1 (fr) 1990-01-31
CA1251140A (fr) 1989-03-14
DK232885A (da) 1985-11-26
US4617315A (en) 1986-10-14
FR2564831A1 (fr) 1985-11-29

Similar Documents

Publication Publication Date Title
TW262461B (da)
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
RU93004484A (ru) Производные пиразола, способ их получения и содержащие их фармацевтические композиции
DK162883D0 (da) N-glucosylerede carboxylsyreamidderivater, fremgangsmade til fremstilling heraf samt deres anvendelse til pavirkning af organismens egen forsvarsmekanisme
LV12291A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai
FR2407926A1 (fr) Derives de quinazoline, leur procede de production et composition pharmaceutique les contenant
DE69125216D1 (de) Aminoalkanesulfonsäurederivate und pharmazeutische Zusammensetzungen davon zur Prävention oder Behandlung von Herzerkrankungen
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
ATE147625T1 (de) Hydantoin- oder imidazolidintrionderivate zur vorbeugung oder behandlung von niereninsuffizienz
DK218189D0 (da) Fumarsyrekonjugat og farmaceutisk praeparat indeholdende en saadan forbindelse
DE2967356D1 (en) Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
IL79910A (en) 5,7-dihydro-6-(thi)oxopyrrolo(2,3-f)benzimidazole,-benzothiazole and-benzoxazoles,6-imines thereof,their preparation and pharmaceutical compositions containing them
DK232885A (da) Immunosuppressivt praeparat
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
ATE110714T1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
FR2658190B1 (fr) Esters d'aminoacides de l'hydroquinone, leur procede de preparation et compositions pharmaceutiques ou cosmetiques les contenant.
DE3162277D1 (en) N-(4-phenyl-2-thiazolyl)-oxamidic-acid-2-ethoxyethylester, process for its preparation and pharmaceutical compositions containing this compound
BE900186A (fr) Compositions fongicides synergiques.
NO161494C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive benzodiazepiner.
ATE71091T1 (de) Tetrahydro-1,2,4-oxadiazin-5-thion-derivate.
DE3887005D1 (de) Mittel zur Behandlung von Nierenbeschwerden.
RU94015603A (ru) Производные 3-гидроксиантраниловой кислоты, способ их получения, фармацевтическая композиция, способ лечения и промежуточные соединения

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment